Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-24

Clinical Trial Update: Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether intravitreal anti-VEGF injections can prevent neovascular glaucoma in patients with large choroidal melanoma treated with prot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-VEGF intravitreal injections

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Ocular Melanoma | Phase 3 | Status: COMPLETED